Craig Gunderson, MD, SFHM
Associate ProfessorDownloadHi-Res Photo
Cards
Appointments
General Internal Medicine
Primary
Additional Titles
Deputy Executive Director, National Hospital Medicine Program, VHA, VHA
Contact Info
Appointments
General Internal Medicine
Primary
Additional Titles
Deputy Executive Director, National Hospital Medicine Program, VHA, VHA
Contact Info
Appointments
General Internal Medicine
Primary
Additional Titles
Deputy Executive Director, National Hospital Medicine Program, VHA, VHA
Contact Info
About
Copy Link
Titles
Associate Professor
Positions outside Yale
Deputy Executive Director, National Hospital Medicine Program, VHA, VHA
Appointments
General Internal Medicine
Associate Professor on TermPrimary
Other Departments & Organizations
- All Institutions
- General Internal Medicine
- Internal Medicine
- Yale Ventures
Education & Training
- Chief Resident
- Yale-New Haven Hospital (2003)
- Medical Resident
- Yale-New Haven Hospital, New Haven CT (2002)
- MD
- Harvard Medical School (1999)
- BA
- Dartmouth College (1991)
Research
Copy Link
Overview
Medical Research Interests
Bacteremia; Hospital Medicine; Meta-Analysis; Patient Safety; Quality Improvement
ORCID
0000-0001-8220-0249
Research at a Glance
Yale Co-Authors
Frequent collaborators of Craig Gunderson's published research.
Publications Timeline
A big-picture view of Craig Gunderson's research output by year.
Research Interests
Research topics Craig Gunderson is interested in exploring.
Alyssa Ann Grimshaw, MBA, MLIS, MPH
David Su, MD
Kiran Turaga, MD, MPH
Lori Bastian, MD, MPH
Elizabeth Godfrey, MD
Jürgen Holleck
77Publications
1,452Citations
Patient Safety
Bacteremia
Quality Improvement
Publications
2026
Association of Social Determinants of Health with Utilization of SGLT2 Inhibitors and GLP1 Receptor Agonists: A Systematic Review and Meta-Analysis
Shah N, Edjimbi J, Daou M, Grimshaw A, Gunderson C, Gupta S. Association of Social Determinants of Health with Utilization of SGLT2 Inhibitors and GLP1 Receptor Agonists: A Systematic Review and Meta-Analysis. Journal Of General Internal Medicine 2026, 1-14. PMID: 41838266, DOI: 10.1007/s11606-026-10178-z.Peer-Reviewed Original ResearchCitationsAltmetricConceptsSocial determinants of healthSocial determinantsSocial determinants of health categoriesSystematic reviewHigh-deprivation neighborhoodsLow-SES patientsDeterminants of healthGLP-1RAOdds of utilizationMeta-analysisLower educational attainmentCross-sectional studyRisk of biasNeighborhood deprivationRandom-effects modelReceptor agonistsResultsTwenty-six studiesMethodsSix databasesPrivately insured patientsInsurance statusType 2 diabetesMetabolic riskGLP-1 receptor agonistsROBINS-I.Medicare Advantage
2025
MON-826 Impact Of Demographic And Social Determinants On Access To SGLT2 Inhibitors And GLP-1 Receptor Agonists: A Systematic Review And Meta-Analysis
Shah N, Edjimbi J, Grimshaw A, Gunderson C, Gupta S. MON-826 Impact Of Demographic And Social Determinants On Access To SGLT2 Inhibitors And GLP-1 Receptor Agonists: A Systematic Review And Meta-Analysis. Journal Of The Endocrine Society 2025, 9: bvaf149.1291. PMCID: PMC12544773, DOI: 10.1210/jendso/bvaf149.1291.Peer-Reviewed Original ResearchConceptsSocial determinants of healthLow-income patientsSocial determinantsSocial determinants of health characteristicsImpact of demographicsMedicare AdvantageSystematic reviewDeterminants of healthSodium-glucose cotransporter2 inhibitorsConfidence intervalsBlack patientsDiabetes mellitusMinority groupsLower income strataRacial minority groupsHigher oddsInsurance statusWeb of Science Core CollectionLowest-incomeHispanic patientsI2 statisticOdds ratioIncome strataReceptor agonistsOvid MEDLINEDietary Patterns for Weight and Glycemic Management in Persons With Type 1 Diabetes: A Meta-analysis of Clinical Trials
Igudesman D, Nally L, Grimshaw A, Gunderson C, Considine E, Jacobsen L, Tosur M, Gottlieb P, Hirsch I, Laffel L, Sherr J, Mathieu C, Pratley R. Dietary Patterns for Weight and Glycemic Management in Persons With Type 1 Diabetes: A Meta-analysis of Clinical Trials. The Journal Of Clinical Endocrinology & Metabolism 2025, 110: 3289-3300. PMID: 40795275, PMCID: PMC12527424, DOI: 10.1210/clinem/dgaf448.Peer-Reviewed Original ResearchCitationsAltmetricConceptsType 1 diabetesNutrition therapyRandomized trialsDiet patternMeta-analysis of clinical trialsMedical nutrition therapyPrecision nutrition approachesModerate certainty evidenceRandom-effects modelPooled confidence intervalsMeta-Analysis guidelinesStratification of resultsDietary guidanceDietary patternsSubgroup analysisClinical trialsPooled resultsCochrane LibraryCertainty evidenceNutritional approachWeight managementRelevant subgroupsGlycemic managementOvid MEDLINEHbA1cConsensus guideline for the management of gastric cancer with synchronous peritoneal metastases
Butensky S, Bansal V, Su D, Waheed M, Nikiforchin A, Gomez‐Mayorga J, Olecki E, Radomski S, Sun B, Turaga K, Gunderson C, Lacy J, Badgwell B, In H, Kennedy T, Yoon H, Greer J, Sundar R, Woo Y, Group P. Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases. Cancer 2025, 131: e35870. PMID: 40558029, DOI: 10.1002/cncr.35870.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsSynchronous peritoneal metastasesManagement of gastric cancerPeritoneal metastasisGastric cancerCytoreductive surgeryConsensus guidelinesLow peritoneal carcinomatosis indexPeritoneal carcinomatosis indexMultidisciplinary preoperative assessmentLimited treatment optionsPatient's goals of careLevel of evidenceGoals of careClinical management pathwaysCytology-negativeCytology-positiveRandomized Controlled TrialsDiagnostic laparoscopySystemic therapySurvival benefitBurden of diseasePreoperative assessmentNonsurgical managementDisease subsetsTreatment optionsConsensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases
Butensky S, Bansal V, Su D, Waheed M, Nikiforchin A, Gomez-Mayorga J, Olecki E, Radomski S, Sun B, Turaga K, Gunderson C, Lacy J, Badgwell B, In H, Kennedy T, Yoon H, Greer J, Sundar R, Woo Y. Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases. Annals Of Surgical Oncology 2025, 1-18. PMID: 40560499, DOI: 10.1245/s10434-025-17361-2.Peer-Reviewed Original ResearchCitationsAltmetricConceptsSynchronous peritoneal metastasesCytoreductive surgeryPeritoneal metastasisConsensus guidelinesLow peritoneal carcinomatosis indexPeritoneal carcinomatosis indexManagement of gastric cancerMultidisciplinary preoperative assessmentLimited treatment optionsNon-surgical managementLevel of evidenceClinical management pathwaysDiagnostic laparoscopyRandomized Controlled TrialsSystemic therapySurvival benefitPreoperative assessmentDisease subsetsTreatment optionsClinical trialsGastric cancerPathway blockBurden of diseasePatientsBackgroundGastric cancerConsensus guideline for the management of patients with appendiceal tumors, part 1: Appendiceal tumors without peritoneal involvement
Godfrey E, Mahoney F, Bansal V, Su D, Hanna D, Lopez‐Ramirez F, Baron E, Turaga K, Benson A, Cusack J, Winer J, Gunderson C, Misdraji J, Shah R, Magge D, Solsky I, Eng C, Eng O, Shergill A, Shen J, Foote M, Group P. Consensus guideline for the management of patients with appendiceal tumors, part 1: Appendiceal tumors without peritoneal involvement. Cancer 2025, 131: e35867. PMID: 40558045, DOI: 10.1002/cncr.35867.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAppendiceal tumorsPeritoneal involvementConsensus guidelinesHeterogeneous group of tumorsSystemic therapy recommendationsGroup of tumorsManagement of patientsAppendiceal malignancyAppendiceal adenocarcinomaIntraperitoneal chemotherapyMucinous neoplasmsMargin statusModified Delphi consensusPathological findingsClinical dataColorectal cancerPathological classificationPathway blockTherapy recommendationsTumorConsensus recommendationsObservational studyTherapy conceptsHeterogeneous groupStandard careConsensus guideline for the management of patients with appendiceal tumors, part 2: Appendiceal tumors with peritoneal involvement
Godfrey E, Mahoney F, Bansal V, Su D, Hanna D, Lopez‐Ramirez F, Baron E, Turaga K, Benson A, Setia N, Winer J, Gunderson C, Shah R, Magge D, Solsky I, Eng C, Eng O, Shergill A, Shen J, Misdraji J, Foote M, Luo W, Group P. Consensus guideline for the management of patients with appendiceal tumors, part 2: Appendiceal tumors with peritoneal involvement. Cancer 2025, 131: e35874. PMID: 40558065, DOI: 10.1002/cncr.35874.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsManagement of appendiceal tumoursAppendiceal tumorsPeritoneal involvementConsensus guidelinesTiming of systemic chemotherapyDelphi consensusHeterogeneous group of tumorsHigh-grade diseaseGroup of tumorsManagement of patientsModified Delphi consensusAppendiceal malignancySystemic chemotherapyUnresectable diseasePeritoneal diseaseSystemic therapySurgical candidatesMost patientsNon-neuroendocrineSurveillance protocolsStandard careColorectal cancerPathological classificationPathway blockConsensus recommendationsConsensus Guideline for the Management of Patients with Appendiceal Tumors, Part 1: Appendiceal Tumors Without Peritoneal Involvement
Godfrey E, Mahoney F, Bansal V, Su D, Hanna D, Lopez-Ramirez F, Baron E, Turaga K, Benson A, Cusack J, Winer J, Gunderson C, Misdraji J, Shah R, Magge D, Solsky I, Eng C, Eng O, Shergill A, Shen J, Foote M. Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 1: Appendiceal Tumors Without Peritoneal Involvement. Annals Of Surgical Oncology 2025, 1-34. PMID: 40560498, DOI: 10.1245/s10434-025-17359-w.Peer-Reviewed Original ResearchCitationsConceptsAppendiceal tumorsPeritoneal involvementConsensus guidelinesHeterogeneous group of tumorsSystemic therapy recommendationsGroup of tumorsManagement of patientsAppendiceal malignancyAppendiceal adenocarcinomaIntraperitoneal chemotherapyMucinous neoplasmsMargin statusModified Delphi consensusPathological findingsClinical dataPathological classificationColorectal cancerPathway blockTherapy recommendationsTumorConsensus recommendationsObservational studyTherapy conceptsHeterogeneous groupStandard careConsensus Guideline for the Management of Patients with Appendiceal Tumors, Part 2: Appendiceal Tumors with Peritoneal Involvement
Godfrey E, Mahoney F, Bansal V, Su D, Hanna D, Lopez-Ramirez F, Baron E, Turaga K, Benson A, Setia N, Winer J, Gunderson C, Shah R, Magge D, Solsky I, Eng C, Eng O, Shergill A, Shen J, Misdraji J, Foote M, Luo W. Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 2: Appendiceal Tumors with Peritoneal Involvement. Annals Of Surgical Oncology 2025, 1-28. PMID: 40560501, DOI: 10.1245/s10434-025-17364-z.Peer-Reviewed Original ResearchCitationsAltmetricConceptsManagement of appendiceal tumoursAppendiceal tumorsPeritoneal involvementConsensus guidelinesTiming of systemic chemotherapyHeterogeneous group of tumorsHigh-grade diseaseGroup of tumorsManagement of patientsDelphi consensusAppendiceal malignancySystemic chemotherapyUnresectable diseasePeritoneal diseaseSystemic therapySurgical candidatesModified Delphi consensusMost patientsNon-neuroendocrineSurveillance protocolsColorectal cancerPathological classificationPathway blockConsensus recommendationsTumorConsensus Guideline for the Management of Malignant Gastrointestinal Obstruction in Patients with Peritoneal Surface Malignancies
Bansal V, Godfrey E, Sadjadi J, Bello R, Kwakman R, Abreu A, Vudatha V, Sparkman B, Freudenberger D, Su D, Turaga K, Micic D, Malec M, Tun S, Polite B, Lambert L, Greenbaum A, Gunderson C, Smith T, Kopecky K, Powers B, Maduekwe U, Ward E. Consensus Guideline for the Management of Malignant Gastrointestinal Obstruction in Patients with Peritoneal Surface Malignancies. Annals Of Surgical Oncology 2025, 1-20. PMID: 40560502, DOI: 10.1245/s10434-025-17362-1.Peer-Reviewed Original ResearchCitationsAltmetricConceptsPeritoneal surface malignanciesPalliative care assessmentSurface malignanciesAssess agreement levelsOverall level of evidenceDelphi consensus processGastrointestinal obstructionClinical management pathwaysDecompression tube placementPoor performance statusLevel of evidenceMalignant gastrointestinal obstructionCare assessmentCare EvaluationRound IConsensus processLimited evidencePeritoneal diseaseNational expertsOptimal management strategyPerformance statusClinical guidanceSurgical interventionConsensus guidelinesPoor prognosis
Academic Achievements & Community Involvement
Copy Link
Activities
activity Journal of General Internal Medicine
2020 - PresentJournal ServiceAssociate Editoractivity Department of Veteran Affairs
2019 - PresentProfessional OrganizationsChairDetailsField Advisory Boardactivity Department of Veteran Affairs
2019 - PresentProfessional OrganizationsConsultantDetailsVISN1 Hospital Medicine Chief Consultantactivity VACT Physician Utilization Management Advisor (PUMA)
2018 - PresentProfessional OrganizationsMemberactivity Department of Veteran Affairs
2017 - PresentProfessional OrganizationsChairDetailsNational Academic Hospitalist Work Group
Honors
honor Finalist, Best Hospital Medicine Abstract, “Risk of Intestinal Necrosis with Sodium Polystyrene Sulfonate(kayexalate): A Systematic Review and Meta-analysis.”
04/14/2021National AwardSociety of General Internal MedicineDetailsUnited Stateshonor Senior Fellow in Hospital Medicine
10/07/2020National AwardSociety of Hospital MedicineDetailsUnited Stateshonor Top 10% of peer reviewers
08/08/2018National AwardJournal of Hospital MedicineDetailsUnited Stateshonor Best Research Poster, “Derivation of a Clinical Model to Predict Unchanged Transthoracic Echocardiograms.”
04/12/2017National AwardSociety of Hospital MedicineDetailsUnited Stateshonor Fellow in Hospital Medicine
10/01/2016National AwardSociety of Hospital MedicineDetailsUnited States
News
Copy Link
News
- June 27, 2025
Best Practices for Peritoneal Surface Malignancies: A Yale-Led National Expert Consensus
- April 24, 2024
Gender Gap in Promotion Within Academic Medicine
- February 14, 2024
Digital Health Tools Help Manage Hypertension for Populations Experiencing Health Disparities
- June 30, 2023
Pancreatic Cancer Risk Lower if Cysts Remain Stable for Five Years
Get In Touch
Copy Link
Contacts
Academic Office Number